Anticonvulsant properties of an aqueous extract of Dysphania ambrosioides (L.) Mosyakin and Clemants (Chenopodiaceae) in mice pilocarpine model of temporal lobe epilepsy
1 Department of Biological Sciences, Faculty of Science, University of Maroua, P.O. Box 814, Maroua, Cameroon.
2 Department of Animal Biology, Faculty of Science, University of Dschang, Cameroon, P.O. Box 67, Dschang, Cameroon.
3 Department of Animal Biology and Physiology, University of Yaounde I, P.O. Box 812, Yaounde, Cameroon.
4 Centre for Research on Medicinal Plants and Traditional Medicine, Institute of Medical Research and Medicinal Plants Studies, P.O. Box 13033, Yaounde, Cameroon.
5 Department of Biological Sciences, Faculty of Science, University of Ngaoundere, P.O. Box 454, Ngaoundéré, Cameroon.
6 Department of Animal Biology and Conservation, Faculty of Science, University of Buea, Cameroon, P.O. Box 63, Buea, Cameroon.
Research Article
GSC Advanced Research and Reviews, 2024, 19(03), 164–175.
Article DOI: 10.30574/gscarr.2024.19.3.0203
Publication history:
Received on 28 April 2024; revised on 06 June 2024; accepted on 08 June 2024
Abstract:
Ethnopharmacological relevance: Dysphania ambrosioides (L.) Mosyakin and Clemants (Chenopodiaceae) is used in traditional Cameroonian medicine to treat epilepsy and anxiety.
Aims of the study: This study aimed to investigate the anticonvulsant effects of Dysphania ambrosioides aqueous extract in mice pilocarpine model of temporal lobe epilepsy.
Materials and Methods: The mice were treatments with distilled water for the normal and negative control, sodium valproate (300 mg/kg) for the positive control, and different doses of an aqueous extract of Dysphania ambrosioides (37, 92.5, 185, 370 mg/kg, p.o) for the test groups. Methyl-scopolamine (1 mg/kg) were injected forty minute later. One hour after the first treatment (first day), epilepsy was induced by intraperitoneal injection of 360 mg/kg pilocarpine. On the seventh day, antioxidant activities and the involvement of GABAergic transmission were determined by measuring the levels of malondialdehyde (MDA), reduced glutathione (GSH), superoxide dismutase (SOD), catalase (CAT), γ-Aminobutyric acid (GABA) and GABA-transaminase (GABA-T), respectively in the hippocampus of sacrificed epileptic mice.
Results: Dysphania ambrosioides (370 mg/kg) strongly protected mice against epileptogenesis by increasing the latency time to status epilepticus (p˂0.001) and decreasing the number of tonic clonic convulsions (p˂0.001). The extract significantly increased the levels of GSH (p˂0.001), CAT (p˂0.001), SOD (p˂0.001) and GABA (p˂0.001), and decreased the levels of MDA (p˂0.001), NO (p˂0.001) and GABA-T (p˂0.001).
Conclusion: The results suggest that the anticonvulsant activities of Dysphania ambrosioides extract are accompanied by its antioxidant effects, and may be mediated at least in part by the GABA neurotransmission.
Keywords:
Anticonvulsant; Temporal Lobe Epilepsy; Γ-Aminobutyric Acid; Oxidative Stress; Dysphania Ambrosioides.
Full text article in PDF:
Copyright information:
Copyright © 2024 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0
